Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.65

€1.65

5.260%
0.086
5.260%
-
 
12.12.25 / Tradegate WKN: A3E5A5 / Name: SynBiotic / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for SynBiotic

sharewise wants to provide you with the best news and tools for SynBiotic, so we directly link to the best financial data sources.

News

EQS-News: SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
EQS-News: SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
EQS-News: SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate
EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate
EQS-News: SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate
EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
EQS-News: Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
EQS-News: Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
EQS-News: Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
EQS-News: Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC